← Leaderboards
Mone Zaidi
Icahn School Of Medicine At Mount Sinai
$25,912,145
Attributed
$47,675,338
Total exposure
20
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.7M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$68,354,043 · 21
By mechanism
R01$33,606,365 · 11
U19$22,998,370 · 3
U01$8,293,749 · 1
R61$2,129,396 · 1
RF1$1,257,163 · 1
R13$69,000 · 4
Top collaborators
- Tony Yuen22 shared
- Terry Francis Davies11 shared
- Clifford J Rosen9 shared
- Li Sun8 shared
- Se-Min Kim6 shared
- Narayan G Avadhani5 shared
- Yelena Ginzburg5 shared
- Vahram Haroutunian5 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Tony Yuen$10,254,831
- Giovanni Manfredi$21,254,007
- Doris A Germain$10,430,941
- Carol Prives$28,176,184
- Anne Schaefer$13,330,813
Others in their field
Top investigators on “Osteoporosis”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
- Steven R Cummings · University Of California San Francisco$56,375,786
- Richard A Gibbs · Baylor College Of Medicine$49,965,365
- Peter J. Snyder · University Of Pennsylvania$36,531,878
- Douglas P. Kiel · Hebrew Rehabilitation Center For Aged$32,610,184
- Eric S. Orwoll · Oregon Health And Science University$28,146,073
Research focus
OsteoporosisBone LossCellsBoneAlzheimer&AposOsteoclastsPreventPhenotypeSkeletalBone ResorptionAffectSerumOvariectomyWomanBone MassBone CellMediatingPituitary HormonesFractureMouse ModelOsteoblastsOsteogenesisHormonesSignal Transduction
Grant awards (87)
FSH - an Aging Hormone?$4,062,689
U19 · FY2025 · AG · contact PI
AAV-mediated Interrogation of the Brain FSH Receptor$2,129,396
R61 · FY2025 · AG
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease$1,616,919
U01 · FY2025 · AG · contact PI
A humanized monoclonal FSH antibody for Alzheimer's Disease and co-occurring health conditions in Down Syndrome$1,257,163
RF1 · FY2025 · AG
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease$1,242,150
R01 · FY2025 · AG · contact PI
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$678,675
R01 · FY2025 · AG
Administrative, Biostatistics and GLP Management Core (ABGMC)$580,385
U19 · FY2025 · AG · contact PI
Targeting FSH for the Therapy of Osteoporosis, Obesity and Neurodegeneration$580,384
U19 · FY2025 · AG · contact PI
The Role of Erythroferrone in Regulating Bone Metabolism in Beta-Thalassemia$570,650
R01 · FY2025 · DK
FSH - an Aging Hormone?$4,204,185
U19 · FY2024 · AG · contact PI
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease$1,652,369
U01 · FY2024 · AG · contact PI
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease$1,267,500
R01 · FY2024 · AG · contact PI
Targeting FSH for the Therapy of Osteoporosis, Obesity and Neurodegeneration$804,105
U19 · FY2024 · AG · contact PI
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$692,527
R01 · FY2024 · AG
The Role of Erythroferrone in Regulating Bone Metabolism in Beta-Thalassemia$543,541
R01 · FY2024 · DK
Administrative, Biostatistics and GLP Management Core (ABGMC)$354,791
U19 · FY2024 · AG · contact PI
FSH - an Aging Hormone?$2,295,185
U19 · FY2023 · AG · contact PI
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease$1,654,767
U01 · FY2023 · AG · contact PI
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease$1,267,500
R01 · FY2023 · AG · contact PI
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$692,527
R01 · FY2023 · AG
The Role of Erythroferrone in Regulating Bone Metabolism in Beta-Thalassemia$587,902
R01 · FY2023 · DK
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$422,499
R01 · FY2023 · AG
The Role of Erythroferrone in Regulating Bone Metabolism in Beta-Thalassemia$406,627
R01 · FY2023 · DK
FSH - an Aging Hormone?$2,298,497
U19 · FY2022 · AG · contact PI
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease$1,657,121
U01 · FY2022 · AG · contact PI
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease$1,267,500
R01 · FY2022 · AG · contact PI
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$692,527
R01 · FY2022 · AG
The Role of Erythroferrone in Regulating Bone Metabolism in Beta-Thalassemia$598,312
R01 · FY2022 · DK
FSH - an Aging Hormone?$2,306,306
U19 · FY2021 · AG · contact PI
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease$1,712,573
U01 · FY2021 · AG · contact PI
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease$1,268,438
R01 · FY2021 · AG · contact PI
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$693,892
R01 · FY2021 · AG
FSH - an Aging Hormone?$2,346,376
U19 · FY2020 · AG · contact PI
Thyrotropin Receptor, Thyrotropin and Mechanisms of Bone Loss$590,680
R01 · FY2020 · DK · contact PI
Thyrotropin Receptor, Thyrotropin and Mechanisms of Bone Loss$407,765
R01 · FY2020 · DK · contact PI
FSH - An Aging Hormone?$407,765
U19 · FY2020 · AG · contact PI
FSH - an Aging Hormone?$2,624,816
U19 · FY2019 · AG · contact PI
Thyrotropin Receptor, Thyrotropin and Mechanisms of Bone Loss$590,680
R01 · FY2019 · DK · contact PI
FSH - an Aging Hormone?$132,886
U19 · FY2019 · AG · contact PI
Ahr and Osteoporosis$654,747
R01 · FY2018 · AR · contact PI
Thyrotropin Receptor, Thyrotropin and Mechanisms of Bone Loss$590,680
R01 · FY2018 · DK · contact PI
Ahr and Osteoporosis$654,747
R01 · FY2017 · AR · contact PI
Thyrotropin Receptor, Thyrotropin and Mechanisms of Bone Loss$627,032
R01 · FY2017 · DK · contact PI
Understanding the skeletal phenotype of Gaucher disease$497,627
R01 · FY2017 · AR · contact PI
Ahr and Osteoporosis$654,747
R01 · FY2016 · AR · contact PI
Understanding the skeletal phenotype of Gaucher disease$497,627
R01 · FY2016 · AR · contact PI
Ahr and Osteoporosis$654,747
R01 · FY2015 · AR · contact PI
Understanding the skeletal phenotype of Gaucher disease$497,627
R01 · FY2015 · AR · contact PI
Exploring The Posterior Pituitary-Bone Connection$371,420
R01 · FY2015 · AG · contact PI
Exploring The Posterior Pituitary-Bone Connection$50,000
R01 · FY2015 · AG · contact PI
Ahr and Osteoporosis$672,122
R01 · FY2014 · AR · contact PI
Understanding the skeletal phenotype of Gaucher disease$497,627
R01 · FY2014 · AR · contact PI
Exploring The Posterior Pituitary-Bone Connection$382,909
R01 · FY2014 · AG · contact PI
Understanding the skeletal phenotype of Gaucher disease$591,503
R01 · FY2013 · AR · contact PI
TSH and Bone$468,011
R01 · FY2013 · DK · contact PI
Exploring The Posterior Pituitary-Bone Connection$361,849
R01 · FY2013 · AG · contact PI
TSH and Bone$486,297
R01 · FY2012 · DK · contact PI
Exploring The Posterior Pituitary-Bone Connection$382,909
R01 · FY2012 · AG · contact PI
Role of FSH in Osreoclast Formation and Function$382,768
R01 · FY2012 · AG · contact PI
TSH and Bone$485,559
R01 · FY2011 · DK · contact PI
Role of FSH in Osreoclast Formation and Function$384,107
R01 · FY2011 · AG · contact PI
Exploring The Posterior Pituitary-Bone Connection$382,909
R01 · FY2011 · AG · contact PI
4th NY Skeletal Biology and Medicine Conference$20,000
R13 · FY2011 · AR · contact PI
TSH and Bone$537,664
R01 · FY2010 · DK · contact PI
Role of FSH in Osreoclast Formation and Function$389,386
R01 · FY2010 · AG · contact PI
TSH and Bone$264,999
R01 · FY2010 · DK · contact PI
TSH and Bone$579,356
R01 · FY2009 · DK · contact PI
Role of FSH in Osreoclast Formation and Function$383,272
R01 · FY2009 · AG · contact PI
Role of FSH in Osreoclast Formation and Function$211,302
R01 · FY2009 · AG · contact PI
3rd Skeletal Biology and Medicine Conference$18,000
R13 · FY2009 · AR · contact PI
Role of FSH in Osreoclast Formation and Function$361,906
R01 · FY2008 · AG · contact PI
Calcium in the regulation of osteoclast formation$449,851
R01 · FY2007 · AG · contact PI
The Role of NFATc1 and Calcineurin in Bone Remodeling$358,550
R01 · FY2007 · DK · contact PI
Calcium in the regulation of osteoclast formation$45,000
R01 · FY2007 · AG · contact PI
Skeletal Biology and Medicine Conference$18,000
R13 · FY2007 · AR · contact PI
Calcium in the regulation of osteoclast formation$452,370
R01 · FY2006 · AG · contact PI
The Role of NFATc1 and Calcineuerin in Bone Remodeling$358,504
R01 · FY2006 · DK · contact PI
Calcium in the regulation of osteoclast formation$452,407
R01 · FY2005 · AG
The Role of NFATc1 and Calcineuerin in Bone Remodeling$356,438
R01 · FY2005 · DK
Skeletal Development and Remodeling in Health, Disease and Aging$13,000
R13 · FY2005 · AR
Calcium in the regulation of osteoclast formation$441,870
R01 · FY2004 · AG
The Role of NFATc1 and Calcineurin in Bone Remodeling$358,358
R01 · FY2004 · DK
Calcium in the regulation of osteoclast formation$461,094
R01 · FY2003 · AG
CD38/ADP RIBOSYL CYCLASE R0LE IN OSTEOCLAST REGULATION$374,219
R01 · FY2003 · AG
CD38/ADP RIBOSYL CYCLASE R0LE IN OSTEOCLAST REGULATION$358,308
R01 · FY2002 · AG
CD38/ADP RIBOSYL CYCLASE R0LE IN OSTEOCLAST REGULATION$352,731
R01 · FY2001 · AG
CD38/ADP RIBOSYL CYCLASE R0LE IN OSTEOCLAST REGULATION$347,317
R01 · FY2000 · AG